Poging GOUD - Vrij

Apple and India might need to woo not just Trump but Xi too

Mint Bangalore

|

June 13, 2025

Beijing's approval would ease Apple's supply chain shift to India

- MIHIR SHARMA

Apple and its main manufacturing contractor, Hon Hai Precision Company, are still betting on India. When Hon Hai—better known as Foxconn—revealed through an exchange filing last week that it was putting another $1.5 billion into its operations there, it will have calmed a few nerves in New Delhi.

Worries about the future of Apple in the country had been set off by US President Donald Trump, who said last month that he had told the company's CEO Tim Cook, "I don't want you building in India." This seemed to contradict hopes, shared by both Cupertino and New Delhi, that most iPhones for the US market would come from India by the end of 2026.

But on the ground, Apple Inc's turn to the South Asian country seems well-entrenched.

Reports have emerged of a new Foxconn campus meant to house 30,000 employees. This would be the largest such effort in India's recent history. And another contract manufacturer, Tata Electronics, is now assembling the iPhone 16 at its South Indian plant.

Yet, CEOs and politicians may have begun to realize that the difficulties involved in shifting—or duplicating—an entire manufacturing ecosystem extend beyond placating Trump. This is a complex environment and there are severe obstacles to moving it out of China. US politics is only one, though perhaps the loudest.

MEER VERHALEN VAN Mint Bangalore

Mint Bangalore

Mint Bangalore

A modern-day throwback to 'Malgudi Days'

Sita Bhaskar's latest novel revisits writer R.K. Narayan’s legacy to explore class, caste, and community in Mysuru

time to read

4 mins

December 13, 2025

Mint Bangalore

Mint Bangalore

Come for the 'baithak', stay for the shopping

Fashion brands are hosting workshops, talks, music gigs and 'baithaks' to take a culture-first approach to customer loyalty

time to read

4 mins

December 13, 2025

Mint Bangalore

Novo Nordisk debuts Ozempic at ₹2,200 a week

Danish drugmaker Novo Nordisk on Friday launched its blockbuster diabetes drug Ozempic in India, with a starting price of ₹2,200 per week.

time to read

1 mins

December 13, 2025

Mint Bangalore

Tushar Adhav and politics of the dance floor

There's a 1983 song by English new wave band Re-Flex that keeps popping up in my mind every time I find myself on an Indian club floor.

time to read

4 mins

December 13, 2025

Mint Bangalore

Mint Bangalore

English's place in history is not black and white

In 1784, two white men joined forces to establish an English school in Thanjavur, Tamil Nadu.

time to read

4 mins

December 13, 2025

Mint Bangalore

Mint Bangalore

Rajasthan limits e-NAM 2.0 pilot amid snags; 1.0 to stay

The Centre restricted e-NAM 2.0 pilot to 10 mandis, including Tonk, Jodhpur and Sujangarh

time to read

3 mins

December 13, 2025

Mint Bangalore

Mint Bangalore

GST cuts, easing inflation drive rural demand revival

India’s rural economy expanded and recovered strongly in late 2025, with consumption, incomes and investment improving after a key tax reform and as inflation eased, a survey showed.

time to read

2 mins

December 13, 2025

Mint Bangalore

Sebi weighs easier unified penalty rules for listed cos

Explores framework like the one for brokers that standardized and reduced fines

time to read

2 mins

December 13, 2025

Mint Bangalore

Mint Bangalore

The loss of Srinagar as a cosmopolitan city

Sameer Hamdani's book brings alive the details that once defined life in one of South Asia's oldest cities but stops short of reflecting on the present

time to read

5 mins

December 13, 2025

Mint Bangalore

Mint Bangalore

'We need 100 Earths to sustain generative Al'

Karen Hao, author of ‘Empire of AI’, explains how AI and tech companies are no less than extractive colonial empires

time to read

4 mins

December 13, 2025

Listen

Translate

Share

-
+

Change font size